News Headlines Article

Report From Key Calif. Agency Raises Concerns About Proposal To Cut Drug Prices
Kaiser Health News

Researchers at one of the nation’s largest public sector health care purchasers weighed in this week with serious concerns about the feasibility of a ballot initiative that seeks to limit how much state programs pay for prescription drugs.

In an analysis presented Tuesday, the California Public Retirement System’s staff lauded the goal of controlling prescription drug prices, but it warned of possible resistance — or even retaliation — by pharmaceutical companies.